Our systematic studies in xenograft models indicate that PCa cells are heterogeneous with respect to their tumor-initiating capacity with the CD44+ cell population harboring both quiescent CSCs and fast proliferating tumor progenitors [38], [42]. This evidence concerns the gene CD44 and posterior cortical atrophy.